冠状动脉粥样硬化性心脏病患者Betatrophin水平及其与三酰甘油和糖化血红蛋白的相关性研究

被引：6

作者：

田清平 ^{[1
]}

唐朝枢 ^{[2
]}

刘梅林 ^{[1
]}

薛林 ^{[3
]}

庞永正 ^{[2
]}

机构：

[1] 北京大学第一医院老年病内科

[2] 北京大学第一医院心血管疾病研究所

[3] 北京大学第一医院心血管内科

来源：

中国现代医学杂志 | 2016年 / 26卷 / 09期

关键词：

Betatrophin; 冠状动脉粥样硬化性心脏病; 糖尿病; 血脂异常;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

1002 ; 100201 ;

摘要：

目的 Betatrophin是一种新发现的影响糖脂代谢的因子。糖尿病和高脂血症是冠状动脉粥样硬化性心脏病(以下简称冠心病)的重要危险因素。比较冠心病患者与对照组的Betatrophin水平,并探讨其与三酰甘油(TG)和糖化血红蛋白(Hb A1c)等因素的相关性。方法测定冠心病组(107例)及与其年龄、性别、体重指数匹配的对照组(35例)的Betatrophin水平。根据Hb A1c水平将冠心病组分为冠心病Hb A1c正常组和冠心病Hb A1c升高组。获取其他临床指标,并测定TG、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL)、高密度脂蛋白胆固醇(HDL)、肌酐(Scr)、尿酸(UA)、超敏C反应蛋白(hs CRP)、脑钠肽(BNP)和同型半胱氨酸(Hcy)水平等,分析Betatrophin与其的相关性。结果冠心病组Betatrophin水平比对照组降低26.6%(P=0.040)。冠心病Hb A1c正常组比对照组降低33.0%(P=0.001),冠心病Hb A1c升高组比冠心病Hb A1c正常组Betatrophin水平升高22.6%(P=0.020)。冠心病组患者Betatrophin与Hb A1c呈正相关(r=0.223,P=0.021)。冠心病组男性患者比女性Betatrophin水平更低[(0.149±0.068)vs(0.181±0.078)ng/ml,P=0.028]。结论 Betatrophin可能是与冠心病患者糖脂代谢调节相关的一个新因子。

引用

页码：39 / 43

页数：5

共 11 条

[1] Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance [J].

Wu, Shimin ;

Gao, Hongjie ;

Ma, Yumei ;

Fu, Lina ;

Zhang, Cai ;

Luo, Xiaoping .

PEDIATRIC DIABETES, 2016, 17 (01) :53-60

[2]

Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests[J] . S. Tokumoto,Y. Hamamoto,K. Fujimoto,E. Yamaguchi,E. Okamura,S. Honjo,H. Ikeda,Y. Wada,A. Hamasaki,H. Koshiyama.Diabet. Med. . 2015 (5)

[3] Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals [J].

Fenzl, Anna ;

Itariu, Bianca K. ;

Kosi, Lana ;

Fritzer-Szekeres, Monika ;

Kautzky-Willer, Alexandra ;

Stulnig, Thomas M. ;

Kiefer, Florian W. .

DIABETOLOGIA, 2014, 57 (06) :1204-1208

[4]

Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes[J] . Daniel Espes,Mats Martinell,Per-Ola Carlsson,Matthew Watt.International Journal of Endocrinology . 2014

[5]

The p38–PGC-1α–irisin–betatrophin axis[J] . Fabian Sanchis-Gomar,Carme Perez-Quilis.Adipocyte . 2014 (1)

[6] Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes [J].

Espes, Daniel ;

Lau, Joey ;

Carlsson, Per-Ola .

DIABETOLOGIA, 2014, 57 (01) :50-53

[7] Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis [J].

Wang, Yan ;

Quagliarini, Fabiana ;

Gusarova, Viktoria ;

Gromada, Jesper ;

Valenzuela, David M. ;

Cohen, Jonathan C. ;

Hobbs, Helen H. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (40) :16109-16114

[8]

Emerging roles of Lipasin as a critical lipid regulator[J] . Ren Zhang,Abdul B. Abou-Samra.Biochemical and Biophysical Research Communications . 2013

[9]

Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation[J] . Peng Yi,Ji-Sun Park,Douglas A. Melton.Cell . 2013 (4)

[10] Novel insights into ChREBP regulation and function [J].

Filhoulaud, Gaelle ;

Guilmeau, Sandra ;

Dentin, Renaud ;

Girard, Jean ;

Postic, Catherine .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2013, 24 (05) :257-268

← 1 2 →